Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor–Induced Ischemic Hindlimb Collateralization and Nitric Oxide–Mediated Angiogenesis
- 23 July 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 95 (2), 154-161
- https://doi.org/10.1161/01.res.0000136344.27825.72
Abstract
Nitric oxide (NO) is a powerful angiogenic mediator acting downstream of vascular endothelial growth factor (VEGF). Both the endothelial NO synthase (eNOS) and the VEGFR-2 receptor colocalize in ca...Keywords
This publication has 30 references indexed in Scilit:
- Caveolin, Caveolae, and Endothelial Cell FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide–Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E −/− Mice In VivoCirculation, 2003
- Caveolin-1 Expression Enhances Endothelial Capillary Tubule FormationPublished by Elsevier ,2002
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Increased numbers of caveolae in retinal endothelium and pericytes in hypertensive diabetic ratsEye, 2001
- Knockdown of Caveolin-1 by Antisense Oligonucleotides Impairs Angiogenesis in Vitro and in VivoBiochemical and Biophysical Research Communications, 2000
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.Journal of Clinical Investigation, 1998
- Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivoFEBS Letters, 1998
- The Endothelial Nitric-oxide Synthase-Caveolin Regulatory CycleJournal of Biological Chemistry, 1998
- Endothelial Nitric Oxide Synthase Targeting to CaveolaeJournal of Biological Chemistry, 1996